Search for: "Eli Global, LLC"
Results 21 - 40
of 68
Sorted by Relevance
|
Sort by Date
30 May 2008, 9:09 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: WHO members near accord on global strategy on IP and health: (Intellectual Property Watch), (GenericsWeb), (Gowlings), (IAM), Copiepresse seeks up to €49 million from Google in lawsuit over right to feature links to publishers’ content on internet: (IPKat), (Ars Technica), (Techdirt), (Out-Law), (IP Law360) Singapore… [read post]
17 Jul 2014, 10:58 am
USA; Accord Healthcare, Inc.; Intas Pharmaceuticals Ltd.; Amneal Pharmaceuticals LLC; Amneal Pharmaceuticals of New York, LLC; Amneal Pharmaceuticals Co. [read post]
29 Aug 2008, 1:25 pm
– Discussion of IPFrontline.com article ‘Understanding Intellectual Property Value’: (IP finance), How to make sure your IP strategy plan is not doomed to failure: (IP Asset Maximizer Blog) Improve venture capital returns with IP portfolio management: (Ezine @rticles) Global - Trade Marks / Domain Names / Brands Trade mark strategy – counterintuitive names: (IP Thinktank), ICANN Intellectual Property Constituency paper on sunrise… [read post]
18 Aug 2010, 12:19 am
Ameridose, LLC (Patent Docs) Neutrokine-? [read post]
27 Feb 2009, 5:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Evista (Raloxifene) – US: CAFC affirms extension of 30-month stay against Teva’s generic Evista: Eli Lilly & Co v Teva Pharmas. [read post]
11 Jul 2008, 4:30 am
Part I – Spicy IP), India: Discussion of grant of Indian patents to Cipla for Fosamax derivative and Nexium derivative: (Spicy IP), India: Draft National Biotechnology Regulatory Authority Bill: (Spicy IP), Ivory Coast: Ivorians increasingly choose fake medicines on price: (Afro-IP), Mexico: New Mexican medicaments approvals regime: an early report: (IP tango), UK: Leave to appeal refused in trade mark infringement proceedings between Eli Lilly and 8PM Chemist concerning the… [read post]
22 Mar 2008, 2:00 am
: (IP finance),ICANN proposes new anti-domain tasting solution: (Out-Law),Three strikes, three countries:France, Japan and Sweden: (Electronic Frontier Foundation)Global - PatentsTRIPS Council: Half of WTO membership backs biodiversity amendment: (Intellectual Property Watch),The costs and benefits of patents to innovators: (Patently-O), (response from Patent Prospector),Discussion of ‘Patent Failure: How Judges, Bureaucrats, and Lawyers Put Innovators at Risk’ by… [read post]
5 Jul 2011, 7:07 am
Patent No. 7,657,629 entitled GLOBAL SERVER LOAD BALANCING and owned by Brocade Communications Systems, Inc. [read post]
5 Jul 2011, 7:07 am
Patent No. 7,657,629 entitled GLOBAL SERVER LOAD BALANCING and owned by Brocade Communications Systems, Inc. [read post]
16 Aug 2019, 6:00 am
Atkins, Patomak Global Partners, LLC, on Sunday, August 11, 2019 Tags: Climate change, Disclosure, Environmental disclosure, ESG, Public firms, Risk disclosure, SEC, Securities regulation, Sustainability, Taxation Managing Legal Risks from ESG Disclosures Posted by David R. [read post]
28 Jul 2010, 12:06 am
(Patent Docs) Zometa (Zoledronic acid) – US: Teva and Novartis settle patent dispute over Zometa (Patent Docs) Zyprexa (Olanzapine) – Canada: Patent Act contains no reference to invalid selection patents: Eli Lilly v Novopharm (Patent Baristas) [read post]
11 Dec 2020, 1:13 pm
Even before his conviction, Lindberg was well-known for having amassed a billion-dollar empire of insurance and annuity companies under his conglomerate, Global Growth, previously called Eli Global. [read post]
30 Jun 2014, 10:28 am
USA; Accord Healthcare, Inc.; Intas Pharmaceuticals Ltd.; Amneal Pharmaceuticals LLC; Amneal Pharmaceuticals of New York, LLC; Amneal Pharmaceuticals Co. [read post]
1 Mar 2018, 2:35 pm
., GlaxoSmithKline LLC and Auxilium (an Endo unit) are on the verge of settlement. [read post]
1 Mar 2018, 2:35 pm
., GlaxoSmithKline LLC and Auxilium (an Endo unit) are on the verge of settlement. [read post]
9 Jan 2009, 3:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: District Court C D California: another victory for Web 2.0, transcoding doesn’t block ‘safe harbor’ defence: Universal Music Group v Veoh (EFF), (Technology & Marketing Law Blog) (Ars Technica) (Techdirt) (Out-Law) Apple ditches DRM; gives record labels variable iTunes pricing (Techdirt)… [read post]
28 Dec 2007, 1:00 am
You can separately subscribe to the IP Thinktank Global week in Review at [feeds.feedburner.com]GlobalWTO grants Antigua and Barbuda the right to waive US intellectual property rights worth up to $21 million: (IPKat), (Against Monopoly), (IAM), (Intellectual Property Law Blog), (The Register), (Patry Copyright Blog),New year brings prospect of new WIPO leader, budget agreement: (Intellectual Property Watch),Importance of IP for development … [read post]
11 Apr 2017, 3:01 pm
As global production chains become more important, these internal enterprise governance systems begin to have profound effects throughout the entire production process, affecting workers and other partner enterprises in many states. [read post]
22 Mar 2011, 4:21 pm
General New IP resource for Pharma, Biotech and Chem – Compulsory licences, comparing national requirements (IP Think Tank) WIPO and India partner to protect traditional knowledge from misappropriation (WIPO) UN Rapporteur for the Right to Health asked to intervene in the TPP negotiation (KEI) Patents and doctors, and the USTR TPP text (KEI) Biotech industry losing interest in the therapeutic potential of RNAi (Patent Docs) India: The curious case of the ‘data exclusivity’ volte… [read post]
16 Aug 2011, 11:35 pm
PTO does not appear to invalidate very many gene patent method claims (Holman’s Biotech IP Blog) US: Machine-or-transformation test after Myriad: Implications to the prosecution of process claims (Patent Law Practice Center) US: Unsuccessful Qui Tam plaintiff asserting false marking claim not immune from costs award: Promote Innovation v Roche Diagnostics (Docket Report) US: FDA releases two medical device draft guidances (FDA Law Blog) US: BIO: Unleashing the promise of biotechnology (pt.4)… [read post]
